Clinical Trials for Lymphoblastic Lymphoma

Find clinical trials for lymphoblastic lymphoma. Discover research opportunities and treatment options in your area.

19 Active Trials Found

Showing 19 trials on this page

Page 1 of 1

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

NCT ID: NCT06514794

This clinical trial is studying a new treatment called WU-CART-007 for patients with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (LBL). The goal of...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States, Los Angeles, California, United States +6 more

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT ID: NCT03314974

This clinical trial is studying a type of treatment called allogeneic hematopoietic stem cell transplant (HCT) for patients with various blood cancers, including leukemia and lymphoma. The aim is t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT ID: NCT07020533

This clinical trial is looking at a new vaccine called the CMV-MVA Triplex vaccine, which aims to help patients who are undergoing a type of stem cell transplant called haploidentical hematopoietic...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States, Boston, Massachusetts, United States +1 more

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

NCT ID: NCT01790152

This clinical trial is exploring how a medication called dexrazoxane hydrochloride affects certain markers in the blood that are linked to heart problems, like cardiomyopathy and heart failure, in ...

Recruiting

Type: observational Locations: New Haven, Connecticut, United States, Lebanon, New Hampshire, United States +77 more

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

NCT ID: NCT05428176

This clinical trial is looking at a special online program designed to help children who have survived cancer, specifically those treated for acute leukemia or lymphoblastic lymphoma. While many of...

Recruiting

Phase: NA Type: interventional Locations: Duarte, California, United States, San Diego, California, United States +2 more

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

NCT ID: NCT05794880

This clinical trial is looking at a new approach to help patients with certain blood cancers, like acute myeloid leukemia and lymphomas, who are in remission. The study focuses on how well a specia...

Recruiting

Phase: NA Type: interventional Locations: Milwaukee, Wisconsin, United States

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

NCT ID: NCT03932903

This clinical trial is testing a new mobile health program designed to help young people with leukemia take their oral chemotherapy medicine regularly. It focuses on adolescents and young adults ag...

Not yet recruiting

Phase: NA Type: interventional

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

NCT ID: NCT03779854

This clinical trial is looking at a new way to help prevent a condition called chronic graft-versus-host disease (GVHD) in children and young adults with certain types of blood cancers, such as leu...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cleveland, Ohio, United States, Iowa City, Iowa, United States +10 more

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT ID: NCT06918431

This clinical trial is studying a new treatment for high-risk adults who have recently been diagnosed with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. The trial is testing a drug ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Cleveland, Ohio, United States, New York, New York, United States +5 more

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

NCT ID: NCT06533748

This clinical trial is exploring a new treatment approach for children and young adults who have recently been diagnosed with B-cell precursor acute lymphoblastic leukemia (ALL) or lymphoblastic ly...

Recruiting

Phase: PHASE2 Type: interventional Locations: Memphis, Tennessee, United States

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

NCT ID: NCT06289673

This clinical trial is looking to improve treatment for children and young adults diagnosed with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LLy). The main goal is to ensure that ...

Recruiting

Phase: PHASE4 Type: interventional Locations: Memphis, Tennessee, United States

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

NCT ID: NCT05602194

This clinical trial is investigating whether adding a medication called levocarnitine to standard chemotherapy can help protect the liver in patients with certain types of leukemia or lymphoma. The...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Cleveland, Ohio, United States +222 more

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

NCT ID: NCT03810196

This clinical trial is studying a new treatment approach for patients, particularly children and young adults under 25 years old, who have certain types of blood cancers like leukemia and lymphoma ...

Recruiting

Phase: NA Type: interventional Locations: Philadelphia, Pennsylvania, United States

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

NCT ID: NCT04195633

This clinical trial is studying a new treatment approach for patients with various types of blood cancers, such as acute leukemia and lymphoma. The treatment combines a donor stem cell transplant w...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

NCT ID: NCT05476770

This clinical trial is studying a new treatment called tagraxofusp for children and young adults with certain types of blood cancers that have not responded to previous treatments. Tagraxofusp work...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, New York, New York, United States +29 more

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

NCT ID: NCT01962636

This clinical trial is investigating a treatment called umbilical cord blood transplantation (UCBT) for patients with specific blood cancers, including different types of leukemia and lymphoma. The...

Recruiting

Phase: NA Type: interventional Locations: Minneapolis, Minnesota, United States

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

NCT ID: NCT06207123

This clinical trial is investigating a new experimental drug called LP-118, which is being tested alongside an existing medication, ponatinib, in patients with relapsed or refractory acute lymphobl...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States

Vitamin A and D Supplementation in Allogeneic HCT

NCT ID: NCT06508099

This clinical trial is exploring the effects of adding vitamin A and vitamin D supplements to the treatment of patients with certain blood cancers, such as leukemia and lymphoma, before they underg...

Recruiting

Phase: PHASE2 Type: interventional Locations: Saint Petersburg, , Russian Federation

BeFluBu vs FluBuRux Conditioning in Haploidentical HCT

NCT ID: NCT06477549

This clinical trial, called BeFluBu vs FluBuRux Conditioning, is studying two different treatment approaches for patients with certain types of blood cancers, such as acute lymphoblastic leukemia a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Saint Petersburg, , Russian Federation

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions